BLM and Bloom syndrome: TFAM was upregulated fourfold in KSVS1452 (BLMKO) cells (Fig. 2F) and 2.5-fold in Bloom- syndrome-patient-derived GM08505 (BLM−/−) cells (Fig. 2G), consistent with increased mitochondrial mass in these cells.